Maraviroc and NeuroAIDS Pathogenesis

Trial Profile

Maraviroc and NeuroAIDS Pathogenesis

Phase of Trial: Phase II/III

Latest Information Update: 30 Jan 2018

At a glance

  • Drugs Maraviroc (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 24 Jan 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Sep 2018.
    • 11 Mar 2016 Status changed from not yet recruiting to recruiting, according to record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top